Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.7K
Overview
32.7K
Allergic Reactions02:06

Allergic Reactions

31.8K
Overview
31.8K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Hypersensitivities01:30

Hypersensitivities

6.7K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification, Risk Assessment, and Mitigation of Cashew Allergen Cross-Contact in Shared Roasting Oil Systems.

Journal of food protection·2025
Same author

Effect of Storage Time and Temperature on the Recovery of Peanut, Milk, and Gluten Residue from Environmental Swabs.

Journal of food protection·2025
Same author

Symptoms at population Eliciting Doses ≤ED05 for 11 priority allergenic foods are mild to moderate.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2025
Same author

Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force.

Allergy·2024
Same author

Peanut allergen Ara h 6 is detectable in blood transfusion products.

Clinical and translational allergy·2023
Same author

Precautionary Allergen Labeling: What Advice Is Available for Health Care Professionals, Allergists, and Allergic Consumers?

The journal of allergy and clinical immunology. In practice·2023
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K

Risk Reduction in Peanut Immunotherapy.

Benjamin C Remington1, Joseph L Baumert2

  • 1Food Allergy Research and Resource Program, Department of Food Science and Technology, University of Nebraska, Lincoln, NE 68588-6207, USA; Remington Consulting Group B.V., Utrecht, the Netherlands.

Immunology and Allergy Clinics of North America
|November 26, 2019
PubMed
Summary
This summary is machine-generated.

Accidental peanut reactions are common. Peanut immunotherapy is a developing treatment to lower this risk, with ongoing research needed for long-term data and risk reduction strategies.

Keywords:
Food allergyPeanutPeanut immunotherapyQuantitative risk assessmentQuantitative risk reductionRelative risk reductionRisk assessmentRisk reduction

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.2K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.6K

Related Experiment Videos

Last Updated: Jan 3, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.2K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.6K

Area of Science:

  • Allergy and Immunology
  • Epidemiology
  • Risk Assessment

Background:

  • Complete avoidance of peanut is challenging, leading to frequent accidental allergic reactions.
  • Peanut allergy affects a significant portion of the population, necessitating effective management strategies.

Purpose of the Study:

  • To review the epidemiology of unexpected peanut allergic reactions.
  • To define and assess risk reduction strategies for peanut allergy.
  • To highlight areas for future research in peanut allergy management.

Main Methods:

  • Literature review on peanut allergy epidemiology.
  • Analysis of risk and risk reduction concepts.
  • Inclusion of quantitative risk assessment examples.

Main Results:

  • Accidental peanut reactions pose a significant public health concern.
  • Immunotherapy shows promise as a risk reduction strategy.
  • Further research, including long-term trials, is crucial.

Conclusions:

  • Peanut immunotherapy is a potential therapeutic option for reducing accidental reactions.
  • Quantitative risk assessment aids in understanding and managing peanut allergy.
  • Continued research is vital to optimize risk reduction and long-term outcomes for peanut-allergic individuals.